SARTORIUS AG-VORZUG (SRT3.DE) Fundamental Analysis & Valuation

FRA:SRT3 • DE0007165631

Current stock price

217.2 EUR
+7.9 (+3.77%)
Last:

This SRT3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SRT3.DE Profitability Analysis

1.1 Basic Checks

  • SRT3 had positive earnings in the past year.
  • SRT3 had a positive operating cash flow in the past year.
  • Each year in the past 5 years SRT3 has been profitable.
  • SRT3 had a positive operating cash flow in each of the past 5 years.
SRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • SRT3 has a worse Return On Assets (1.65%) than 68.75% of its industry peers.
  • The Return On Equity of SRT3 (5.97%) is worse than 68.75% of its industry peers.
  • SRT3 has a worse Return On Invested Capital (5.11%) than 68.75% of its industry peers.
  • SRT3 had an Average Return On Invested Capital over the past 3 years of 4.49%. This is below the industry average of 7.18%.
  • The 3 year average ROIC (4.49%) for SRT3 is below the current ROIC(5.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.65%
ROE 5.97%
ROIC 5.11%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
SRT3.DE Yearly ROA, ROE, ROICSRT3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SRT3's Profit Margin of 4.58% is on the low side compared to the rest of the industry. SRT3 is outperformed by 62.50% of its industry peers.
  • In the last couple of years the Profit Margin of SRT3 has declined.
  • SRT3 has a Operating Margin (15.73%) which is in line with its industry peers.
  • SRT3's Operating Margin has declined in the last couple of years.
  • SRT3 has a Gross Margin of 45.59%. This is in the better half of the industry: SRT3 outperforms 68.75% of its industry peers.
  • In the last couple of years the Gross Margin of SRT3 has declined.
Industry RankSector Rank
OM 15.73%
PM (TTM) 4.58%
GM 45.59%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
SRT3.DE Yearly Profit, Operating, Gross MarginsSRT3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1

2. SRT3.DE Health Analysis

2.1 Basic Checks

  • SRT3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SRT3 remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, SRT3 has more shares outstanding
  • SRT3 has a better debt/assets ratio than last year.
SRT3.DE Yearly Shares OutstandingSRT3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SRT3.DE Yearly Total Debt VS Total AssetsSRT3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • SRT3 has an Altman-Z score of 2.18. This is not the best score and indicates that SRT3 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SRT3 has a Altman-Z score (2.18) which is in line with its industry peers.
  • SRT3 has a debt to FCF ratio of 9.70. This is a negative value and a sign of low solvency as SRT3 would need 9.70 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 9.70, SRT3 is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.22 is on the high side and indicates that SRT3 has dependencies on debt financing.
  • SRT3 has a worse Debt to Equity ratio (1.22) than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.7
Altman-Z 2.18
ROIC/WACC0.6
WACC8.53%
SRT3.DE Yearly LT Debt VS Equity VS FCFSRT3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that SRT3 may have some problems paying its short term obligations.
  • SRT3 has a Current ratio of 0.91. This is amonst the worse of the industry: SRT3 underperforms 87.50% of its industry peers.
  • A Quick Ratio of 0.52 indicates that SRT3 may have some problems paying its short term obligations.
  • The Quick ratio of SRT3 (0.52) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.52
SRT3.DE Yearly Current Assets VS Current LiabilitesSRT3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. SRT3.DE Growth Analysis

3.1 Past

  • SRT3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.02%.
  • The Earnings Per Share has been growing slightly by 1.76% on average over the past years.
  • SRT3 shows a small growth in Revenue. In the last year, the Revenue has grown by 3.20%.
  • Measured over the past years, SRT3 shows a quite strong growth in Revenue. The Revenue has been growing by 8.66% on average per year.
EPS 1Y (TTM)-11.02%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-80.37%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.9%

3.2 Future

  • Based on estimates for the next years, SRT3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.14% on average per year.
  • SRT3 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.11% yearly.
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SRT3.DE Yearly Revenue VS EstimatesSRT3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
SRT3.DE Yearly EPS VS EstimatesSRT3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

1

4. SRT3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 57.16, the valuation of SRT3 can be described as expensive.
  • Based on the Price/Earnings ratio, SRT3 is valued a bit more expensive than 75.00% of the companies in the same industry.
  • SRT3 is valuated expensively when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
  • SRT3 is valuated quite expensively with a Price/Forward Earnings ratio of 32.39.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SRT3 indicates a slightly more expensive valuation: SRT3 is more expensive than 75.00% of the companies listed in the same industry.
  • SRT3's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.75.
Industry RankSector Rank
PE 57.16
Fwd PE 32.39
SRT3.DE Price Earnings VS Forward Price EarningsSRT3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRT3 indicates a rather expensive valuation: SRT3 more expensive than 81.25% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as SRT3.
Industry RankSector Rank
P/FCF 36.7
EV/EBITDA 19.7
SRT3.DE Per share dataSRT3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as SRT3's earnings are expected to grow with 18.59% in the coming years.
PEG (NY)2.98
PEG (5Y)32.42
EPS Next 2Y18.45%
EPS Next 3Y18.59%

3

5. SRT3.DE Dividend Analysis

5.1 Amount

  • SRT3 has a yearly dividend return of 0.44%, which is pretty low.
  • SRT3's Dividend Yield is a higher than the industry average which is at 0.57.
  • Compared to an average S&P500 Dividend Yield of 1.82, SRT3's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

  • On average, the dividend of SRT3 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 62.38% of the earnings are spent on dividend by SRT3. This is not a sustainable payout ratio.
  • SRT3's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP62.38%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
SRT3.DE Yearly Income VS Free CF VS DividendSRT3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SRT3.DE Dividend Payout.SRT3.DE Dividend Payout, showing the Payout Ratio.SRT3.DE Dividend Payout.PayoutRetained Earnings

SRT3.DE Fundamentals: All Metrics, Ratios and Statistics

SARTORIUS AG-VORZUG

FRA:SRT3 (4/30/2026, 5:36:15 PM)

217.2

+7.9 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength11.49
Industry Growth92
Earnings (Last)04-23
Earnings (Next)07-23
Inst Owners1.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.26B
Revenue(TTM)3.55B
Net Income(TTM)162.70M
Analysts80
Price Target378.25 (74.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0.73
Dividend Growth(5Y)15.65%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-37.31%
Min EPS beat(2)-82.17%
Max EPS beat(2)7.55%
EPS beat(4)2
Avg EPS beat(4)-20.08%
Min EPS beat(4)-82.17%
Max EPS beat(4)7.55%
EPS beat(8)3
Avg EPS beat(8)-10.51%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-0.97%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-0.97%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.48%
PT rev (3m)-2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-5.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-1.83%
Valuation
Industry RankSector Rank
PE 57.16
Fwd PE 32.39
P/S 4.58
P/FCF 36.7
P/OCF 18.34
P/B 5.96
P/tB N/A
EV/EBITDA 19.7
EPS(TTM)3.8
EY1.75%
EPS(NY)6.71
Fwd EY3.09%
FCF(TTM)5.92
FCFY2.73%
OCF(TTM)11.84
OCFY5.45%
SpS47.47
BVpS36.41
TBVpS-34.21
PEG (NY)2.98
PEG (5Y)32.42
Graham Number55.797 (-74.31%)
Profitability
Industry RankSector Rank
ROA 1.65%
ROE 5.97%
ROCE 7.2%
ROIC 5.11%
ROICexc 5.54%
ROICexgc 21.21%
OM 15.73%
PM (TTM) 4.58%
GM 45.59%
FCFM 12.47%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
ROICexc(3y)4.83%
ROICexc(5y)9.64%
ROICexgc(3y)16.7%
ROICexgc(5y)28.15%
ROCE(3y)6.33%
ROCE(5y)12.7%
ROICexgc growth 3Y-19.62%
ROICexgc growth 5Y-7.23%
ROICexc growth 3Y-29.84%
ROICexc growth 5Y-12.08%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.7
Debt/EBITDA 3.4
Cap/Depr 104.8%
Cap/Sales 12.48%
Interest Coverage 3.05
Cash Conversion 90.28%
Profit Quality 272.4%
Current Ratio 0.91
Quick Ratio 0.52
Altman-Z 2.18
F-Score7
WACC8.53%
ROIC/WACC0.6
Cap/Depr(3y)122.42%
Cap/Depr(5y)145.08%
Cap/Sales(3y)13.7%
Cap/Sales(5y)13.08%
Profit Quality(3y)357.39%
Profit Quality(5y)249.46%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.02%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%-80.37%
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.14%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%1.9%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y9.11%
EBIT growth 1Y37.28%
EBIT growth 3Y-20.66%
EBIT growth 5Y2.17%
EBIT Next Year81.03%
EBIT Next 3Y32.63%
EBIT Next 5Y24.44%
FCF growth 1Y205.87%
FCF growth 3Y23.14%
FCF growth 5Y7.81%
OCF growth 1Y27.16%
OCF growth 3Y4.46%
OCF growth 5Y10.35%

SARTORIUS AG-VORZUG / SRT3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.


Can you provide the valuation status for SARTORIUS AG-VORZUG?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.


What is the profitability of SRT3 stock?

SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for SRT3 stock?

The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 19.16% in the next year.


Can you provide the dividend sustainability for SRT3 stock?

The dividend rating of SARTORIUS AG-VORZUG (SRT3.DE) is 3 / 10 and the dividend payout ratio is 62.38%.